Literature DB >> 11893567

Mechanical alternans and restitution in failing SHHF rat left ventricles.

Cristian Dumitrescu1, Prakash Narayan, Igor R Efimov, Yuanna Cheng, M Judith Radin, Sylvia A McCune, Ruth A Altschuld.   

Abstract

We examined mechanical alternans and electromechanical restitution in normal and failing rat hearts. Alternans occurred at 5 Hz in failing versus 9 Hz in control hearts and was reversed by 300 nM isoproterenol, 6 mM extracellular Ca(2+), 300 nM -BAY K 8644, or 50 nM ryanodine. Restitution curves comprised phase I, which was completed before relaxation of the steady-state beat, and phase II, which occurred later. Phase I action potential area and developed pressure ratios were significantly reduced in the failing versus control hearts. Phase II was a monoexponential increase in relative developed pressure as the extrasystolic interval was increased. The plateau of phase II was significantly elevated in failing hearts. Thapsigargin (3 microM) plus ryanodine (200 nM) potentiated phase I to a significantly greater extent in control versus failing hearts and abolished phase II in both groups. The results suggest that both regulation of Ca(2+) influx across the sarcolemma and Ca(2+) release by the sarcoplasmic reticulum may contribute to altered excitation-contraction coupling in the failing spontaneously hypertensive heart failure prone rat heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893567     DOI: 10.1152/ajpheart.00466.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

Review 1.  Local calcium gradients during excitation-contraction coupling and alternans in atrial myocytes.

Authors:  Lothar A Blatter; Jens Kockskämper; Katherine A Sheehan; Aleksey V Zima; Jörg Hüser; Stephen L Lipsius
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

2.  Early development of intracellular calcium cycling defects in intact hearts of spontaneously hypertensive rats.

Authors:  Sunil Kapur; Gary L Aistrup; Rohan Sharma; James E Kelly; Rishi Arora; Jiabo Zheng; Mitra Veramasuneni; Alan H Kadish; C William Balke; J Andrew Wasserstrom
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-01       Impact factor: 4.733

Review 3.  Cellular mechanisms of arrhythmogenic cardiac alternans.

Authors:  Kenneth R Laurita; David S Rosenbaum
Journal:  Prog Biophys Mol Biol       Date:  2008-02-15       Impact factor: 3.667

4.  Regulation of cardiac alternans by β-adrenergic signaling pathways.

Authors:  Stela M Florea; Lothar A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 5.  Cellular mechanism of cardiac alternans: an unresolved chicken or egg problem.

Authors:  Yun-Liang Zang; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

Review 6.  Cardiac alternans and intracellular calcium cycling.

Authors:  Joshua N Edwards; Lothar A Blatter
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-07       Impact factor: 2.557

7.  Spark-induced sparks as a mechanism of intracellular calcium alternans in cardiac myocytes.

Authors:  Robert Rovetti; Xiaohua Cui; Alan Garfinkel; James N Weiss; Zhilin Qu
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

8.  Intracellular Ca alternans: coordinated regulation by sarcoplasmic reticulum release, uptake, and leak.

Authors:  Lai-Hua Xie; Daisuke Sato; Alan Garfinkel; Zhilin Qu; James N Weiss
Journal:  Biophys J       Date:  2008-06-06       Impact factor: 4.033

9.  Alternans of cardiac calcium cycling in a cluster of ryanodine receptors: a simulation study.

Authors:  T Tao; S C O'Neill; M E Diaz; Y T Li; D A Eisner; H Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-30       Impact factor: 4.733

10.  Dependency of calcium alternans on ryanodine receptor refractoriness.

Authors:  Enric Alvarez-Lacalle; Inma R Cantalapiedra; Angelina Peñaranda; Juan Cinca; Leif Hove-Madsen; Blas Echebarria
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.